Govt plans to ramp up production of Covaxin to 10 crore doses per month

Centre has said that it plans to ramp up the production of Bharat Biotech’s Covaxin from 1.5 crore doses to about 10 crore doses every month.

NITI Aayog member Dr VK Paul said, total production of Covaxin doses will be further scaled up to 13 crore doses a month when three public sector undertakings start manufacturing the vaccine.

Briefing media persons, he said that the government will look at more private players to scale up the production of Covaxin.

Haffkine Biopharmaceuticals in Mumbai, Indian Immunologicals in Hyderabad and Bulandshahr-based Bharat Immunologicals and Biologicals are the three public sector units that will manufacture Covaxin vaccine.

Dr Paul said, Bharat Biotech’s vaccine technology is being shared with the three PSUs with a provision of 150-crore rupees funding to scale up production.


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies